Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antipsychotic Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939892A reveals a green Ru-catalyzed route for quetiapine intermediates. Achieve high purity and yield with water as the only byproduct for cost-effective API manufacturing.
Patent CN109384744A enables direct synthesis of Quetiapine intermediate with high purity. Reduces steps and cost for pharmaceutical manufacturing supply chains globally.
Patent CN112521318A reveals a novel route for methyl 4-amino-5-thiophenyl-2-methoxybenzoate, offering cost reduction and scalable manufacturing for antipsychotic drug producers.
Patent CN115368317A details a novel salting-out method for 1-(2,3-dichlorophenyl)piperazine hydrochloride, ensuring low dimer impurities and reduced solvent usage.
Patent CN110577482B reveals a novel 2-step one-pot synthesis for Amisulpride. Discover cost-effective manufacturing, high purity yields, and reliable supply chain solutions.